Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Cancergenetik i Stockholm AB

Closing information (x1000 SEK)

Closing information 2024/03 2023/03 2022/03
Turnover 0 More Arrow 1,467 More Arrow 2,014
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -295 More Arrow 310 Less Arrow 289
EBITDA -298 More Arrow 310 Less Arrow 289
Total assets 554 More Arrow 741 Less Arrow 455
Current assets 554 More Arrow 741 Less Arrow 455
Current liabilities 194 Less Arrow 76 Less Arrow 25
Equity capital 360 More Arrow 634 Less Arrow 416
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2024/03 2023/03 2022/03
Solvency 65.0% More Arrow 85.6% More Arrow 91.4%
Turnover per employee 0 More Arrow 1,467 More Arrow 2,014
Profit as a percentage of turnover 21.1% Less Arrow 14.3%
Return on assets (ROA) -53.2% More Arrow 41.8% More Arrow 63.5%
Current ratio 285.6% More Arrow 975.0% More Arrow 1820.0%
Return on equity (ROE) -81.9% More Arrow 48.9% More Arrow 69.5%
Change turnover -1,467 More Arrow -547 More Arrow -39
Change turnover % -100% More Arrow -27% More Arrow -2%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/03 2023/03 2022/03
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.